The good news is that regulators are taking actions to address these problems
The most measurable changes described in the studies were observed over a 12 week period
CrossRef Hepatobiliary Cancers in Saudi Arabia From 2000 to 2025 Khalil I Alshammari, Ibrahim Ginawi, Hisham Sherfi, Hussain G Ahmed Cureus .2025;[Epub] CrossRef Drug-loaded indocyanine green J-aggregates activate metalloimmunotherapy for sustained photothermal therapy of hepatocellular carcinoma Kaiming He, Desheng Chen, Dongzi Zhu, Wenjie Zheng, Lei Lyu, Mingshen Zhang, Zeping Chen, Xiaowen Wang, Yongwei Hu, Binsheng Fu Journal of Nanobiotechnology .2025;[Epub] CrossRef Application of LI-RADS CT/MRI Radiation Treatment Response Assessment Version 2024: a study after transarterial radioembolization for hepatocellular carcinoma Jaeseung Shin, Sunyoung Lee, Ja Kyung Yoon, Kyowon Gu, Sun-Young Baek, Dong-Ho Hyun, Gyoung Min Kim, Jong Yun Won Japanese Journal of Radiology .2025
Semaglutide has strong long-term safety data when used appropriately
Id be very cautious about products like that, says Raj Dasgupta, MD , associate professor of clinical medicine at the University of California, Riverside School of Medicine
